Therapeutic Pipeline
At Aurealcrat Inc., we have steadily deepened the science that underpins our computational discovery platform, strengthening its predictive power and expanding its reach across discovery and development. As these capabilities matured, our organization advanced in parallel—evolving from a tools-centric posture to an integrated, outcome-driven engine for therapeutic innovation.
To capture the full value of this platform for areas of significant unmet need, we established a dedicated therapeutics organization. Our pipeline embodies a disciplined, evidence-weighted approach that fuses physics-informed computation, AI-enabled modeling, and modern translational biology—advancing differentiated candidates with clear paths from hypothesis to the clinic. We do not sell peptides, medicines or chemicals.
Therapeutics Pipeline
Integrating physics-informed computation, AI, and translational biology to advance differentiated therapeutics.
Sevda Manap, Hande Akar, Hilal Medetalibeyoğlu, Abdurrahman Atalay, Zehra Can, Yakup Kara, Muzaffer Alkan, Murat Beytur, Haydar Yüksek, A. Buğra Ortaakarsu “Structure-guided discovery of submicromolar 1,2,4-triazole–Schiff-base inhibitors of glutathione reductase” International Journal of Biological Macromolecules